Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
口服SF3B1调节剂H3B-8800治疗髓系肿瘤的I期首次人体剂量递增研究
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-021-01328-9
Steensma, David P; Wermke, Martin; Klimek, Virginia M; Greenberg, Peter L; Font, Patricia; Komrokji, Rami S; Yang, Jay; Brunner, Andrew M; Carraway, Hetty E; Ades, Lionel; Al-Kali, Aref; Alonso-Dominguez, Juan M; Alfonso-Piérola, Ana; Coombs, Catherine C; Deeg, H Joachim; Flinn, Ian; Foran, James M; Garcia-Manero, Guillermo; Maris, Michael B; McMasters, Malgorzata; Micol, Jean-Baptiste; De Oteyza, Jaime Perez; Thol, Felicitas; Wang, Eunice S; Watts, Justin M; Taylor, Justin; Stone, Richard; Gourineni, Vikram; Marino, Alyssa J; Yao, Huilan; Destenaves, Benoit; Yuan, Xiaobin; Yu, Kun; Dar, Sara; Ohanjanian, Lernik; Kuida, Keisuke; Xiao, Jianjun; Scholz, Catherine; Gualberto, Antonio; Platzbecker, Uwe